MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 19, 2020

Total Value ($000): $415,058 (100.0% shares, 0.0% debt)

Holdings (12)

— Repare Therapeutics, Inc. 17.7%

Value ($000) $73,489 Shares 2,388,337 Est. Cost $31.02 Unrealized —

— TCR2 Therapeutics, Inc. 16.5%

Value ($000) $68,498 Shares 3,370,982 Est. Cost $14.28 Unrealized —

— Harpoon Therapeutics, Inc. 16.0%

Value ($000) $66,234 Shares 3,898,422 Est. Cost $14.79 Unrealized —

— iTeos Therapeutics, Inc. 14.0%

Value ($000) $58,112 Shares 2,355,557 Est. Cost $24.67 Unrealized —

— Epizyme, Inc. 8.2%

Value ($000) $34,057 Shares 2,854,737 Est. Cost $22.28 Unrealized —

— MEI Pharma, Inc. 7.6%

Value ($000) $31,630 Shares 10,137,859 Est. Cost $3.11 Unrealized —

— Turning Point Therapeutics, Inc. 6.5%

Value ($000) $26,967 Shares 308,686 Est. Cost $44.66 Unrealized —

ADCT ADC Therapeutics, Inc. 4.3%

Value ($000) $17,803 Shares 539,648 Est. Cost $38.22 Unrealized +13.2%

— G1 Therapeutics, Inc. 4.0%

Value ($000) $16,445 Shares 1,423,794 Est. Cost $26.43 Unrealized —

— YmAbs Therapeutics, Inc. 3.1%

Value ($000) $12,949 Shares 337,291 Est. Cost $31.25 Unrealized —

— Merus N.V. 2.0%

Value ($000) $8,411 Shares 700,879 Est. Cost $16.09 Unrealized —

AUTL Autolus Therapeutics Limited 0.1%

Value ($000) $463 Shares 39,740 Est. Cost $13.21 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Repare Therapeutics, Inc.	2,388,337	$73,489	17.7%	$31.02	—	Common	760273102
—	TCR2 Therapeutics, Inc.	3,370,982	$68,498	16.5%	$14.28	—	Common	87808K106
—	Harpoon Therapeutics, Inc.	3,898,422	$66,234	16.0%	$14.79	—	Common	41358P106
—	iTeos Therapeutics, Inc.	2,355,557	$58,112	14.0%	$24.67	—	Common	46565G104
—	Epizyme, Inc.	2,854,737	$34,057	8.2%	$22.28	—	Common	29428V104
—	MEI Pharma, Inc.	10,137,859	$31,630	7.6%	$3.11	—	Common	552798202
—	Turning Point Therapeutics, Inc.	308,686	$26,967	6.5%	$44.66	—	Common	90041T108
ADCT	ADC Therapeutics, Inc.	539,648	$17,803	4.3%	$38.22	+13.2%	Common	H0036K147
—	G1 Therapeutics, Inc.	1,423,794	$16,445	4.0%	$26.43	—	Common	3621LQ109
—	YmAbs Therapeutics, Inc.	337,291	$12,949	3.1%	$31.25	—	Common	984241109
—	Merus N.V.	700,879	$8,411	2.0%	$16.09	—	Common	N5749R100
AUTL	Autolus Therapeutics Limited	39,740	$463	0.1%	$13.21	—	Common	05280R100